← Open Payments lookup

KATHERINE KWONG: Open Payments

NPI 1508240375 · SANTA CLARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,260 in 10 payments from 10 companies in 2025. Trend: 2023 $330 · 2024 $1,249 · 2025 $1,260

Food & beverage: $1,260
CompanyPaymentsAmount
Dexcom, Inc.1$145
Galderma Laboratories, L.P.1$140
Edwards Lifesciences Corporation1$137
Neurelis, Inc.1$134
Gilead Sciences, Inc.1$127
Madrigal Pharmaceuticals1$125
Lilly USA, LLC1$117
ARGENX US, INC.1$115
Otsuka Pharmaceutical Development & Commercialization, Inc.1$112
Janssen Pharmaceuticals, Inc1$109

Products named: DEXCOM G7 GSS (161), NEMLUVIO, SAPIEN 3 Ultra RESILIA, VALTOCO, REZDIFFRA, KISUNLA, VYVGART, SPRAVATO.

Industry payments across CA — which companies pay providers there.